IRIS Accounts Production v26.3.0.614 15764558 Board of Directors Board of Directors 1.7.25 30.6.26 30.6.26 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh157645582025-06-30157645582026-06-30157645582025-07-012026-06-30157645582024-06-05157645582024-06-062025-06-30157645582025-06-3015764558ns15:EnglandWales2025-07-012026-06-3015764558ns14:PoundSterling2025-07-012026-06-3015764558ns10:Director12025-07-012026-06-3015764558ns10:Director22025-07-012026-06-3015764558ns10:PrivateLimitedCompanyLtd2025-07-012026-06-3015764558ns10:SmallEntities2025-07-012026-06-3015764558ns10:AuditExemptWithAccountantsReport2025-07-012026-06-3015764558ns10:SmallCompaniesRegimeForDirectorsReport2025-07-012026-06-3015764558ns10:SmallCompaniesRegimeForAccounts2025-07-012026-06-3015764558ns10:FullAccounts2025-07-012026-06-301576455812025-07-012026-06-3015764558ns10:RegisteredOffice2025-07-012026-06-3015764558ns5:CurrentFinancialInstruments2026-06-3015764558ns5:CurrentFinancialInstruments2025-06-3015764558ns5:ShareCapital2026-06-3015764558ns5:ShareCapital2025-06-3015764558ns5:FurtherSpecificReserve3ComponentTotalEquity2026-06-3015764558ns5:FurtherSpecificReserve3ComponentTotalEquity2025-06-3015764558ns5:ComputerSoftware2025-07-012026-06-3015764558ns5:PlantMachinery2025-07-012026-06-3015764558ns5:ComputerEquipment2025-07-012026-06-3015764558ns5:ComputerSoftware2026-06-3015764558ns5:PlantMachinery2026-06-3015764558ns5:ComputerEquipment2026-06-3015764558ns5:AdditionsToInvestments2026-06-3015764558ns5:RevaluationsIncreaseDecreaseInInvestments2026-06-3015764558ns5:CostValuation2026-06-3015764558ns5:WithinOneYearns5:CurrentFinancialInstruments2026-06-3015764558ns5:WithinOneYearns5:CurrentFinancialInstruments2025-06-30157645582ns10:Director22025-06-30157645582ns10:Director22024-06-05157645582ns10:Director22025-07-012026-06-30157645582ns10:Director22024-06-062025-06-30157645582ns10:Director22026-06-30157645582ns10:Director22025-06-3015764558ns10:Director112025-06-3015764558ns10:Director112024-06-0515764558ns10:Director112025-07-012026-06-3015764558ns10:Director112024-06-062025-06-3015764558ns10:Director112026-06-3015764558ns10:Director112025-06-30
REGISTERED NUMBER: 15764558 (England and Wales)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2026

FOR

TALENT THERAPEUTICS LTD

TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Report of the Accountants 8

TALENT THERAPEUTICS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2026







DIRECTORS: L Gibson
Dr K R Gibson





REGISTERED OFFICE: 45 Queen Street
Deal
CT14 6EY





REGISTERED NUMBER: 15764558 (England and Wales)





ACCOUNTANTS: Higson & Co (Deal) Ltd
45 Queen Street
Deal
Kent
CT14 6EY

TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)

BALANCE SHEET
30 JUNE 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 6,750 -
Tangible assets 5 1,366 -
Investments 6 47,277 -
55,393 -

CURRENT ASSETS
Debtors 7 37,521 -
Cash at bank and in hand 67,357 70,725
104,878 70,725
CREDITORS
Amounts falling due within one year 8 41,460 30,843
NET CURRENT ASSETS 63,418 39,882
TOTAL ASSETS LESS CURRENT
LIABILITIES

118,811

39,882

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Fair value reserve 9 (6,570 ) -
Retained earnings 124,381 38,882
118,811 39,882

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)

BALANCE SHEET - continued
30 JUNE 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 October 2026 and were signed on its behalf by:




Dr K R Gibson - Director



L Gibson - Director


TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2026

1. STATUTORY INFORMATION

Talent Therapeutics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially recognised at cost basis. The assets are amortised over the estimated useful life and reviewed annually for impairments under the cost model.

Digital assets are considered to have an indefinite useful life and are therefore not amortised. Digital assets are reviewed annually for impairment.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 33% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2026

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Digital
assets
£   
COST
Additions 10,500
Disposals (3,750 )
At 30 June 2026 6,750
NET BOOK VALUE
At 30 June 2026 6,750

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
Additions 525 1,357 1,882
At 30 June 2026 525 1,357 1,882
DEPRECIATION
Charge for year 144 372 516
At 30 June 2026 144 372 516
NET BOOK VALUE
At 30 June 2026 381 985 1,366

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
Additions 56,037
Revaluations (8,760 )
At 30 June 2026 47,277
NET BOOK VALUE
At 30 June 2026 47,277

TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2026

6. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 30 June 2026 is represented by:

Other
investments
£   
Valuation in 2026 (8,760 )
Cost 56,037
47,277

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 30,000 -
Directors' current accounts 5,331 -
Deferred tax asset 2,190 -
37,521 -

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors - 119
Tax 29,310 16,895
VAT 9,742 11,637
Directors' current accounts 932 932
Accrued expenses 1,476 1,260
41,460 30,843

9. RESERVES
Fair
value
reserve
£   
Transfer to fair value reserve (6,570 )

At 30 June 2026 (6,570 )

TALENT THERAPEUTICS LTD (REGISTERED NUMBER: 15764558)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2026

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the year ended 30 June 2026 and the period ended 30 June 2025:

2026 2025
£    £   
L Gibson
Balance outstanding at start of year 620 -
Amounts advanced - 3,196
Amounts repaid 312 (2,576 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 932 620

Dr K R Gibson
Balance outstanding at start of year 312 -
Amounts advanced (9,500 ) 312
Amounts repaid 3,857 -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,331 ) 312

TALENT THERAPEUTICS LTD

REPORT OF THE ACCOUNTANTS TO THE DIRECTORS OF
TALENT THERAPEUTICS LTD

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 30 June 2026 set out on pages one to twelve and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Higson & Co (Deal) Ltd
45 Queen Street
Deal
Kent
CT14 6EY


Date: .............................................